Neurogene Inc. ( NGNE) - Key Metrics
NGNE Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$1.53 | -$1.05 | -$1.07 |
| 2026Q1 | $0 | -$1.39 | -$1.17 | -$1.18 |
| 2025Q4 | $0 | -$1.60 | -$1.08 | -$1.08 |
| 2025Q3 | $0 | -$0.99 | -$0.93 | -$0.94 |
| 2025Q2 | $0 | -$1.05 | -$0.92 | -$0.93 |
NGNE Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -5.14 |
| 2026Q1 | 0% | -3.63 |
| 2025Q4 | 0% | -3.22 |
| 2025Q3 | 0% | -4.38 |
| 2025Q2 | 0% | -3.56 |
NGNE
Price: $23.25
52 week price:
Earnings Per Share: -5.04 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 405.3 million